Navigation Links
Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
Date:6/9/2008

the prostate. SARMs provide the opportunity to design tissue-selective, orally delivered anabolic therapies for bone loss and/or muscle wasting caused by aging, burns and trauma, cancer, chronic kidney disease, end-stage renal disease, chronic obstructive pulmonary disease (COPD), and other diseases.

About Sarcopenia

About 17% of men and 24% of women under the age of 70 suffer from age-related muscle wasting, or sarcopenia. The degenerative loss of skeletal muscle mass and strength contributes to frailty, immobility, and the loss of independence in older adults, with prevalence rising to more than 50% in men and women over 80 years of age. An estimated nine million Americans over the age of 65 suffer from sarcopenia, and there are currently no FDA-approved treatment options available. This deterioration of skeletal strength can also exacerbate other age-related conditions such as osteoarthritis and osteoporosis. Additional chronic diseases that involve loss of muscle strength with a significant impact on quality of life include cancer cachexia, chronic obstructive pulmonary disease (COPD), and chronic renal disease.

ABOUT RADIUS (http://www.radiuspharm.com)

Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. Radius has raised $91.5 million in private equity financing since its establishment in 2003 and is based in Cambridge, Massachusetts.

Contact:

Nick Harvey

Chief Financial Officer

(617) 551-4704


'/>"/>
SOURCE Radius Health
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Radius Completes Enrollment of Phase II Clinical Trial of BA058 for Osteoporosis
2. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
3. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
4. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
5. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
6. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
7. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
8. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
9. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
10. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
11. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will ... March 31, 2013, before market on Tuesday, May 28, 2013.  ... 28, 2013, at 8:00 a.m. EDT (May 28, 2013 at ... results and provide an update on recent corporate developments. ...
(Date:5/16/2013)...  PTC Therapeutics, Inc., today announced that it has ... U.S. Securities and Exchange Commission ("SEC") relating to the ... number of shares to be offered and the price ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) J.P. ... managers for the offering. Cowen and Company is acting ...
(Date:5/16/2013)... , May 16, 2013  Alere Inc. (NYSE: ... charge of their health at home through the merger of ... of $3.00 per share on its Series B Convertible Perpetual ... 15, 2013 to holders of record of Series B stock ... Such payment will cover the amount of all dividends ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... Decline in Global Measles Deaths, Joint News Release: ... and WASHINGTON, Nov. 29, Measles deaths in Africa fell ... 396,000 to 36,000, reaching the,United Nations 2010 goal to ... spectacular gains achieved in Africa helped generate a strong,decline ...
... Nov. 29 AIDS Action Council,joins organizations and individuals ... 20th annual World AIDS Day, December 1, 2007. Since ... awareness,about the HIV/AIDS pandemic and to reinvigorate global, national, ... and 2008 theme of World AIDS Day is leadership. ...
Cached Medicine Technology:Measles Deaths in Africa Plunge by 91% 2Measles Deaths in Africa Plunge by 91% 3Measles Deaths in Africa Plunge by 91% 4AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic 2
(Date:5/19/2013)... SUNDAY, May 19 (HealthDay News) -- Although spring arrived ... the summer allergy season will still be strong, according ... at Birmingham. Dr. Richard Waguespack, clinical professor in ... often results in a robust summer allergy season. However, ... as sneezing, wheezing and coughing, he added. "Tree ...
(Date:5/19/2013)... St. Louis, MO (PRWEB) May 19, 2013 ... Member Conference, May 19-22, 2013, at the Walt Disney ... the latest trends in supply chain innovation, care delivery ... a much different dynamic in all healthcare markets, ... necessary part of the conversation,” said Todd Ebert, Amerinet ...
(Date:5/19/2013)... May 19, 2013 Actos lawsuit ... litigation now underway in U.S. District Court, Western District ... dated May 3rd, the Court has modified the litigation’s ... eight cases rather than four. The next Status Conference ... May 23rd. (In re: Actos Product Liability Litigation, MDL ...
(Date:5/19/2013)... May 19, 2013 According to ... Analysis and Forecast (2013 – 2018): By Applications ... Industrial)); Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) ... image sensor market was $8.00 billion in 2012 ... 2018, at an estimated CAGR of 3.84% from ...
(Date:5/19/2013)... Fat Burning Furnace developed by Rob ... people with fat burning diet plans, training ... Burning Furnace package, people will receive the Fat Burning ... quickly. The Fat Burning Furnace manual includes fat loss ... muscle mass. In addition, this book covers step-by-step instructions, ...
Breaking Medicine News(10 mins):Health News:Managing Seasonal Allergies 2Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2
... 19 (HealthDay News) -- Scientists say they,ve identified the first ... known as plaque psoriasis. "We have searched for almost ... psoriasis," study senior author Anne Bowcock, professor of genetics at ... a university news release. "Individually, the rare mutations we have ...
... Brophy Marcus HealthDay Reporter , THURSDAY, April 19 ... may want to let it go. A new study suggests ... happier years later in life. Researchers from the University ... 60-somethings to see how it affected their emotional health. ...
... Australia have discovered that salicylate, the active ingredient in ... (AMP-activated protein kinase), a key player in regulating cell ... cellular fuel-gauge is switched on by exercise and the ... scientists at McMaster University, the University of Dundee and ...
... of pregnant women and newborns for the presence of ... according to a Vanderbilt study now available online and ... study,s senior author, Buddy Creech, M.D., MPH, assistant professor ... carrying MRSA may risk transmitting an infection to their ...
... HealthDay Reporter , THURSDAY, April 19 (HealthDay News) ... been diagnosed with early-onset Alzheimer,s disease, celebrated women,s basketball coach ... University of Tennessee Lady Vols team. "I,ve loved being ... recognize that the time has come to move into the ...
... , THURSDAY, April 19 (HealthDay News) -- Most people know ... cancer diagnosis low: Don,t smoke, eat healthy, exercise and get ... choices, and a new report suggests that lawmakers and private ... easier ones to make. ...
Cached Medicine News:Health News:Gene Behind Psoriasis Identified, Researchers Say 2Health News:'No Regrets' Outlook May Make for Sunnier Old Age 2Health News:'No Regrets' Outlook May Make for Sunnier Old Age 3Health News:McMaster researchers find potential for new uses of old drug 2Health News:Concerns about MRSA for expectant mothers may be unfounded 2Health News:Basketball Legend Pat Summitt Leaving as Tennessee Women's Coach 2Health News:Basketball Legend Pat Summitt Leaving as Tennessee Women's Coach 3Health News:Basketball Legend Pat Summitt Leaving as Tennessee Women's Coach 4Health News:Healthy Lifestyle Choices Could Cut Cancer Rates: Report 2Health News:Healthy Lifestyle Choices Could Cut Cancer Rates: Report 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: